[Studies for dynamics of reverse transcriptase inhibiting antibody in sera from HIV-1 infected individuals]. 1998

F Odawara, and K Sano, and T Otake, and S Okubo, and T Nakano, and T Takasaki, and H Misaki, and M Nakai
Diagnostic Division, Asahi Chemical Industry, Co., Ltd.

Antibodies inhibiting human immunodeficiency virus type 1 (HIV-1) reverse transcriptase activity (RTI-antibody), Binding inhibition antibody (BI-antibody) and polymerization inhibition antibody (PI-antibody) were investigated for their ability to inhibiting RT activity in 248 HIV-1 infected individuals and 99 healthy individuals. In BI-antibody, high titer samples were determined more in than in RTI- and PI-antibodies. No significance was indicated between AC, ARC and AIDS is any antibody, however, progression from AC to AIDS was poled to high titer and low titer in RTI- and BI-antibodies. Moreover, time course of each antibody levels in the same infected individuals were resulted in no change, going up or down through all the experimental term, though all samples were collected in AC. These results were suggested that the determination factor of each stage in HIV progression would be multiple, and that the various dynamics of RTI-, BI- and PI-antibodies in the same infected individuals might be caused in the term from HIV infection to AIDS progression, prognosis or appearing of the drug resistant strain but stages of the disease.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse

Related Publications

F Odawara, and K Sano, and T Otake, and S Okubo, and T Nakano, and T Takasaki, and H Misaki, and M Nakai
January 1989, Nihon rinsho. Japanese journal of clinical medicine,
F Odawara, and K Sano, and T Otake, and S Okubo, and T Nakano, and T Takasaki, and H Misaki, and M Nakai
August 1995, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
F Odawara, and K Sano, and T Otake, and S Okubo, and T Nakano, and T Takasaki, and H Misaki, and M Nakai
April 1988, Science (New York, N.Y.),
F Odawara, and K Sano, and T Otake, and S Okubo, and T Nakano, and T Takasaki, and H Misaki, and M Nakai
February 1988, AIDS research and human retroviruses,
F Odawara, and K Sano, and T Otake, and S Okubo, and T Nakano, and T Takasaki, and H Misaki, and M Nakai
February 2023, AIDS research and human retroviruses,
F Odawara, and K Sano, and T Otake, and S Okubo, and T Nakano, and T Takasaki, and H Misaki, and M Nakai
August 1994, AIDS research and human retroviruses,
F Odawara, and K Sano, and T Otake, and S Okubo, and T Nakano, and T Takasaki, and H Misaki, and M Nakai
May 2001, AIDS (London, England),
F Odawara, and K Sano, and T Otake, and S Okubo, and T Nakano, and T Takasaki, and H Misaki, and M Nakai
February 2019, The journal of physical chemistry. B,
F Odawara, and K Sano, and T Otake, and S Okubo, and T Nakano, and T Takasaki, and H Misaki, and M Nakai
December 2002, AIDS (London, England),
F Odawara, and K Sano, and T Otake, and S Okubo, and T Nakano, and T Takasaki, and H Misaki, and M Nakai
September 2012, Physical chemistry chemical physics : PCCP,
Copied contents to your clipboard!